www.vastbiome.com Open in urlscan Pro
160.153.52.231  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 *  




MAPPING THE GUT-IMMUNE AXIS FOR BETTER MEDICINES ™

Solving medicine’s toughest unmet needs by unlocking the power of the human gut
to discover small molecule therapeutics.




UNCOVERING THE 95% DARK MATTER



▸ We believe that the cure to immunologic disorders is hidden amongst a vast
network of gut microbial DNA.
▸ We built the largest gut-DNA atlas to access novel therapeutic chemical space.


OUR PROCESS




MULTI-OMIC DATA

Generating patient-derived clinical metadata and biospecimen samples


AI

Predicting viable biomarkers and therapeutic candidates


SYNTHETIC BIOLOGY

Production of small molecules via cell-free expression


SCREENING ASSAYS

Functional assays for high throughput phenotypic screening


WE ARE USING PROPRIETARY METHODS IN GENOMIC SEQUENCING, ARTIFICIAL INTELLIGENCE,
AND SYNTHETIC BIOLOGY TO DISCOVER BIOMARKERS AND NOVEL THERAPEUTICS FOR THE MOST
CHALLENGING IMMUNOLOGIC DISORDERS.


OPEN POSITIONS



Senior Bioinformatics Scientist: Metagenomics and Metabolomics (South San
Francisco)

Finance Operations Manager (South San Francisco)

Research Assistant in Cell Free Protein Synthesis (South San Francisco)


TEAM



Ayin Vala, MS
Co-founder, Chief AI Officer

Claire Toney, BS
Research Assistant

Dora Yu, PhD
Scientist

Hanane Arib, MS
Head of Clinical
Operations

Kareem Barghouti, MBA
Co-founder, CEO

Lanying Ma, PhD
Senior Bioinformatics Scientist

Mark Ashwell, PhD
Head of Chemistry

Peter McCaffrey, MD
Co-founder, CTO

Riccardo Guidi, PhD
Associate Director, Immunology Research

Subramanya Rao, PhD
Scientist

Alex Cogdill, PhD
Cancer Immunology

Jonathan Kotula, PhD
Synthetic Biology

Matt Durrant, PhD
Computational Biology

Stephen Nayfach, PhD
Bioinformatics

Tomer Altman, PhD
Bioinformatics





ADVISORS



Elaine Stracker, JD, PhD
Former EVP & General Counsel at Pharmacyclics

Ken Blount, PhD
CSO BiochemistryRebiotix

Kovi Bessoff, MD, PhD
Co-founder, CSO

Milad Alucozai, MS, MPH
Serial Entrepreneur, Advisor to AstraZeneca

Mohan Iyer, MBA
Former COO at Pendulum,
CBO at Second Genome

Nadim Ajami, PhD
Executive Director of Microbiome at MD Anderson

Phil Jones, PhD
VP of Therapeutic Discovery at MD Anderson

Wasim Malik, PhD
Managing Partner at Iaso, Former CDO at Roivant





SUPPORTED BY







PARTNERS





HIGHLIGHTED PRESS RELEASE



Jan 2022 | VastBiome Announces PARADIGM, a Large Exploratory Prospective Data
Collection

Nov 2021 | Bristol Myers Squibb awards “Golden Ticket” to VastBiome

Nov 2021 | CEO of VastBiome sits down with Neil Littman to discuss using AI to
map the gut microbiome to discover novel therapies

Dec 2020 | VastBiome Raises $4.5 Million in Seed Funding

Oct 2020 | Wall Street Journal features VastBiome as a portfolio company of
Merck’s Global Health Innovation Fund

Oct 2020 | Startus Insights selects VastBiome as Top 5 BioTech Startups in
microbiome analysis to watch out for

Sep 2020 | Stanford’s StartX accepts VastBiome to its cohort of MedTech
companies

Sep 2020 | NYU’s Endless Frontier Labs accepts VastBiome to help grow its
business

Apr 2020 | VastBiome to present at National Health Symposium

Feb 2020 | VastBiome selected to present at Microbiome Movement Drug Development
in London

Oct 2019 | Medstartr publishes on VastBiome

Sep 2019 | VastBiome selected to present at Stanford Medicine’s Frontier of
AI-Assisted Medicine

July 2019 | UCSF Rosenman Institute Interviews VastBiome on Cancer Immunology &
the Microbiome

May 2019 | VastBiome interviewed by Antimicrobial Regeneration Consortium

Mar 2019 | VastBiome wins grant at SXSW

Mar 2019 | VastBiome’s poster accepted to NVIDIA’s GTC Conference

Oct 2018 | Illumina announces VastBiome into Illumina Accelerators Eighth
Investment Cycle


CONTACT US




LOCATION

280 Utah Ave. South San Francisco, CA


PHONE

(650) 479-5539


EMAIL

info@vastbiome.com

adminHome11.11.2021

© Vast Life Sciences, Inc. 2022

 * 
 *